Mosunetuzumab for CLL MRD Clearance

Clinical trial NCT07052695 · RECRUITING

Trial details

NCT number: NCT07052695
Sponsor: Inhye Ahn
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Leukemia Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Lymphoma

Start date: 2025-11-24
Primary completion: 2028-12-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.